Procyon Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
20,632
-1,904
-8% -$168K 0.08% 212
2026
Q2
$1.76M Buy
22,536
+1,027
+5% +$82.8K 0.08% 207
2026
Q1
$1.86M Buy
21,509
+6,173
+40% +$591K 0.09% 198
2025
Q4
$1.47M Sell
15,336
-51
-0.3% -$4.95K 0.07% 219
2025
Q3
$1.47M Buy
15,387
+3,303
+27% +$304K 0.09% 184
2025
Q2
$1.05M Sell
12,084
-3,586
-23% -$304K 0.1% 184
2025
Q1
$1.32M Sell
15,670
-3,527
-18% -$316K 0.08% 228
2024
Q4
$1.53M Buy
19,197
+2,795
+17% +$242K 0.1% 197
2024
Q3
$1.48M Buy
16,402
+1,335
+9% +$112K 0.1% 195
2024
Q2
$1.19M Buy
15,067
+1,047
+7% +$85.8K 0.09% 203
2024
Q1
$1.22M Sell
14,020
-158
-1% -$13.5K 0.09% 201
2023
Q4
$1.17M Sell
14,178
-3,058
-18% -$233K 0.1% 191
2023
Q3
$1.35M Buy
17,236
+1,190
+7% +$100K 0.14% 164
2023
Q2
$1.41M Buy
16,046
+622
+4% +$53.5K 0.18% 131
2023
Q1
$1.24M Sell
15,424
-86
-0.6% -$7.01K 0.21% 115
2022
Q4
$1.21M Buy
15,510
+6,458
+71% +$523K 0.22% 107
2022
Q3
$731K Sell
9,052
-1,301
-13% -$117K 0.18% 116
2022
Q2
$929K Sell
10,353
-672
-6% -$68.1K 0.2% 105
2022
Q1
$1.22M Buy
11,025
+661
+6% +$69.8K 0.25% 87
2021
Q4
$1.07M Buy
10,364
+275
+3% +$31.8K 0.23% 96
2021
Q3
$1.26M Buy
10,089
+1,819
+22% +$235K 0.32% 76
2021
Q2
$1.03M Buy
8,270
+872
+12% +$109K 0.28% 79
2021
Q1
$874K Buy
7,398
+525
+8% +$61.5K 0.39% 68
2020
Q4
$805K Sell
6,873
-5,906
-46% -$650K 0.39% 66
2020
Q3
$1.33M Sell
12,779
-102
-0.8% -$10.2K 0.74% 39
2020
Q2
$1.18M Buy
12,881
+1,111
+9% +$107K 0.63% 37
2020
Q1
$1.06M Buy
11,770
+208
+2% +$22.1K 0.71% 37
2019
Q4
$1.31M Buy
+11,562
New +$1.27M 0.8% 32

Other funds holding MDT

Procyon Advisors's MDT Position: Q3 2026 in Review

Procyon Advisors reduced its Medtronic (MDT) stake by 8.4% in Q3 2026, selling an estimated $168K and leaving 20,632 shares worth $1.78M. The position accounts for 0.08% of the portfolio, ranked #212.

Procyon Advisors first reported a position in MDT in Q4 2019 and has held it in 28 quarters since. The position peaked at $1.86M in Q1 2026. 917 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Procyon Advisors held 20,632 shares of Medtronic worth $1.78M as of Q3 2026.
  • Procyon Advisors sold 1,904 Medtronic shares in Q3 2026, an estimated $168K.
  • Medtronic made up 0.08% of Procyon Advisors's portfolio in Q3 2026, its #212 holding.
  • Procyon Advisors first reported a position in Medtronic in Q4 2019 and has held it in 28 quarters since.
  • Procyon Advisors's Medtronic position peaked at $1.86M in Q1 2026.
  • 917 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.